Spatial variability of genomic aberrations in a large glioblastoma resection specimen

Abstract. In the present study, the distribution of genetic aberrations in a glioblastoma resection specimen of unusually large size (9×8×2 cm) was investigated using comparative genomic hybridization (CGH). CGH was performed on 20 samples taken from the specimen, and the genetic aberrations found were compared with the regional histology. The samples were histopathologically graded according to WHO criteria, and a division in high- and low-grade areas and infiltration rims was made. In high-grade areas, low-grade areas as well as infiltration rims, gains on 10p11.2-pter (14/20), 11q12-q22 (6/20) and losses on 4q13-qter (9/20), 10q22-qter (8/20), 11p14-pter (5/20), 13q12-qter (7/20) were revealed. Gains on 1q21-32 (2/4) and losses on 7p21-pter (3/4) were exclusively found in the high-grade areas. In the low-grade tumor samples and in the infiltration rim, gains on 16p11.2-pter (6/16), 17p11.2-pter (6/16), 17q11.2-qter (5/16), 20q11.2-q13 (3/16) and deletions on 5q31-qter (4/16) were detected. Gains on 7q21-qter (8/11) and 8q11.2-qter (6/11), and loss of chromosome 9 (4/11) and the Y-chromosome (4/11) were found in the high-grade and low-grade samples, not in the infiltration rims. The finding of a set of identical chromosomal aberrations throughout the resection specimen, most of which have been previously reported in gliomas, confirms a mechanism of clonal tumor proliferation operative in gliomas. The previously unreported genetic alterations which were predominantly traced in the tumor rims, might reflect either selection for properties related to infiltrating behavior, or genomic instability of subclones. The findings illustrate the importance of searching for high-grade genetic aberrations in low-grade tumor samples taken from cases in which sampling error is suspected.

[1]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[2]  K. Sasaki,et al.  Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. , 1998, Cancer research.

[3]  S. Leenstra,et al.  Amplification of the anonymous marker D17S67 in malignant astrocytomas , 1994, Genes, chromosomes & cancer.

[4]  A. Raap,et al.  Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. , 1992, Journal of neurosurgery.

[5]  Alec C. Kimmelman,et al.  Loss of heterozygosity of chromosome 10p in human gliomas. , 1996, Genomics.

[6]  G. Reifenberger,et al.  Analysis of p53 Mutation and Epidermal Growth Factor Receptor Amplification in Recurrent Gliomas with Malignant Progression , 1996, Journal of neuropathology and experimental neurology.

[7]  P. Kleihues,et al.  Genetics of Glioma Progression and the Definition of Primary and Secondary Glioblastoma , 1997 .

[8]  H. Ng,et al.  Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors. , 1999, Journal of neuropathology and experimental neurology.

[9]  M. Ricoul,et al.  A cytogenetic study of 19 recurrent gliomas. , 1994, Cancer genetics and cytogenetics.

[10]  R. White,et al.  Allelotype of human malignant astrocytoma. , 1990, Cancer research.

[11]  J. Delattre,et al.  Oncogene amplification in human gliomas: a molecular cytogenetic analysis. , 1994, Oncogene.

[12]  I. Petersen,et al.  p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. , 1992, Cancer research.

[13]  F. Waldman,et al.  Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization , 1995, International journal of cancer.

[14]  K. Sasaki,et al.  Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization , 1998, Genes, chromosomes & cancer.

[15]  S. Leenstra,et al.  Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas. , 1992, Cancer research.

[16]  M. Prados,et al.  Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade , 1998, Genes, chromosomes & cancer.

[17]  K. Mrózek,et al.  Accumulation of chromosomal changes in human glioma progression. A cytogenetic study of 50 cases. , 1995, Cancer genetics and cytogenetics.

[18]  H. Scherthan,et al.  Detection of Complex Genetic Alterations in Human Glioblastoma Multiforme Using Comparative Genomic Hybridization , 1996, Journal of neuropathology and experimental neurology.

[19]  J. Cairncross,et al.  Gliomas in families: chromosomal analysis by comparative genomic hybridization. , 1998, Cancer genetics and cytogenetics.

[20]  C. Sommer,et al.  Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. , 1996, Oncogene.

[21]  S. Coons,et al.  Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. , 1995, Cancer research.

[22]  A. Jauch,et al.  Copyright ©) American Society for Investigative Pathology Comparative Genomic Hybridization of Human Malignant Gliomas Reveals Multiple Amplification Sites and Nonrandom Chromosomal Gains and Losses , 2022 .

[23]  G. Reifenberger,et al.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. , 1994, The American journal of pathology.

[24]  O. G. Dodge,et al.  Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.

[25]  T. Sekiya,et al.  Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas , 1998, Oncogene.

[26]  D. Louis,et al.  The retinoblastoma gene is involved in malignant progression of astrocytomas , 1994, Annals of neurology.

[27]  M. J. van den Bent,et al.  Genetic aberrations in oligodendroglial tumours: an analysis using comparative genomic hybridization (CGH) , 1999, The Journal of pathology.